Comparative study of muscle-sparing latissimus dorsi vs breast implants following total mastectomy.

INTRODUCTION: With 60,000 cases per year, breast cancer is the most frequent type of cancer in France, and a quarter of these cases require mastectomy. Following the surgery, breast reconstruction can be indicated. Two of the available techniques are breast implants (BIs) and muscle-sparing latissimus dorsi (MSLD). The aim of this study was to compare postoperative complications of each approach and thus help the surgeon and the patient in making an informed decision before surgery. MATERIALS AND METHODS: This descriptive, retrospective and single-centre study was conducted in the Croix Rousse hospital in Lyon (France) between 1 July 2018 and 1 July 2023. It included women aged ≥18 years who underwent mastectomy followed by (immediate or delayed) breast reconstruction with MSLD or BI. Complications were recorded and evaluated using the Clavien-Dindo classification. RESULTS: Over the course of the study, 92 patients were managed with MSLD reconstruction and 63 patients with BI. We observed a complication rate of 62% in the BI group and 39% in the MSLD group (odds ratio [OR]=0.16; p < 0.005). Body mass index (BMI) significantly impacted this rate (OR=1.11; p = 0.01), whereas smoking status and diabetes did not. No complication occurred more predominantly than others. A second surgery was required more often in the BI group (p < 0.005). There were no severe complications (>Grade 4). CONCLUSION: MSLD predicted fewer complications and was associated with a shorter hospital stay compared with implants, suggesting that it may be a preferable option for breast reconstruction.

[Management of puerperal hematomas]. / Prise en charge des hématomes puerpéraux.

Puerperal hematoma is a rare complication of the postpartum period remaining imperfectly known. We present an update of knowledge on this particular type of puerperal haemorrhage threatening in some cases maternal prognosis. In vulvovaginal hematomas, the diagnosis relies on clinical findings whereas it requires medical imaging in the retroperitoneal localisations. Therapeutic approach also largely differs according to the localisation of the hematoma. We thus propose a synthesis of the critical care strategies depending on the type of the puerperal hematoma.

[Laparoscopic adjustable gastric banding and pregnancy]. / Anneau gastrique et grossesse.

UNLABELLED: Laparoscopic adjustable gastric banding and pregnancy. OBJECTIVES: We intend to understand the interactions between pregnancy and laparoscopic adjustable gastric banding in order to ensure better care for patients. MATERIALS AND METHOD: We undertake an observation retrospective study, from January 2004 to December 2005, at Edouard Herriot hospital, of births from women with laparoscopic adjustable gastric banding with a study of gastric banding interaction with pregnancy, neonatal outcomes and postpartum; we read through literature. RESULTS: We studied 35 pregnancies from women with a gastric banding out of 5773 pregnancies (0.6%); we noted lower obstetrical complications with loss of weight that we attributed to the gastric banding comparing with the pregnancies before the gastric banding: three hypertensive diseases and one gestational diabetes had been avoided; we observed a complication due to the gastric banding: occlusive syndrome, which implied gastric banding calibration during immediate postpartum. CONCLUSION: Our record folders are in accordance with literature and confirm improvement in obstetrical prognostic. Waiting for stabilization of weight is recommended before starting a pregnancy after gastric banding surgery; the adjustment of the gastric banding during pregnancy must be undertaken individually according to symptoms (vomiting, gain of weight...).